Adirondack Trust Company’s Pacira BioSciences PCRX Stock Holding History

Adirondack Trust Company’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.2K	Hold	600	–	–	﹤0.01%	376
2026 Q1	$13.6K	Hold	600	–	–	﹤0.01%	364
2025 Q4	$15.5K	Hold	600	–	–	0.01%	349
2025 Q3	$15.5K	Hold	600	–	–	0.01%	363
2025 Q2	$14.3K	Hold	600	–	–	0.01%	338
2025 Q1	$14.9K	Hold	600	–	–	0.01%	318
2024 Q4	$11.3K	Hold	600	–	–	﹤0.01%	349
2024 Q3	$9.03K	Hold	600	–	–	﹤0.01%	371
2024 Q2	$17.2K	Hold	600	–	–	0.01%	315
2024 Q1	$17.5K	Hold	600	–	–	0.01%	312
2023 Q4	$17.8K	Hold	600	–	–	0.01%	312
2023 Q3	$18.4K	Hold	600	–	–	0.01%	288
2023 Q2	$21.8K	Hold	600	–	–	0.01%	264
2023 Q1	$24.5K	Hold	600	–	–	0.01%	252
2022 Q4	$23.2K	Hold	600	–	–	0.01%	252
2022 Q3	$32K	Hold	600	–	–	0.02%	227
2022 Q2	$35K	Hold	600	–	–	0.02%	212
2022 Q1	$46K	Hold	600	–	–	0.02%	201
2021 Q4	$36K	Hold	600	–	–	0.02%	204
2021 Q3	$31K	Hold	600	–	–	0.01%	216
2021 Q2	$36K	Hold	600	–	–	0.02%	209
2021 Q1	$42K	Hold	600	–	–	0.02%	195
2020 Q4	$40K	Hold	600	–	–	0.02%	188
2020 Q3	$36K	Hold	600	–	–	0.02%	176
2020 Q2	$32K	Hold	600	–	–	0.02%	180
2020 Q1	$20K	Hold	600	–	–	0.02%	190
2019 Q4	$26K	Hold	600	–	–	0.02%	199
2019 Q3	$23K	Hold	600	–	–	0.02%	208
2019 Q2	$26K	Hold	600	–	–	0.02%	206
2019 Q1	$24K	Hold	600	–	–	0.02%	195
2018 Q4	$26K	Hold	600	–	–	0.02%	186
2018 Q3	$29K	Buy	+600	New	+$25.9K	0.02%	189

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Adirondack Trust Company's PCRX Position: Q2 2026 in Review

Adirondack Trust Company held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 600 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

Adirondack Trust Company first reported a position in PCRX in Q3 2018 and has held it in 32 quarters since. The position peaked at $46K in Q1 2022. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Adirondack Trust Company held 600 shares of Pacira BioSciences worth $15.2K as of Q2 2026.
Adirondack Trust Company left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up ﹤0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #376 holding.
Adirondack Trust Company first reported a position in Pacira BioSciences in Q3 2018 and has held it in 32 quarters since.
Adirondack Trust Company's Pacira BioSciences position peaked at $46K in Q1 2022.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.